<VariationArchive RecordType="classified" VariationID="192386" VariationName="SOX9, 96-KB TRIPLICATION, UPSTREAM REGULATORY REGION" VariationType="copy number gain" Accession="VCV000192386" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-04" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="190173" VariationID="192386">
      <GeneList>
        <Gene Symbol="SOX9" FullName="SRY-box transcription factor 9" GeneID="6662" HGNC_ID="HGNC:11204" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="72121020" stop="72126416" display_start="72121020" display_stop="72126416" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="70117160" stop="70122560" display_start="70117160" display_stop="70122560" Strand="+" />
          </Location>
          <OMIM>608160</OMIM>
          <Haploinsufficiency last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX9">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX9">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>SOX9, 96-KB TRIPLICATION, UPSTREAM REGULATORY REGION</Name>
      <VariantType>copy number gain</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="NCBI36" AssemblyAccessionVersion="GCF_000001405.12" forDisplay="true" AssemblyStatus="previous" Chr="17" Accession="NC_000017.9" innerStart="67018227" innerStop="67114737" display_start="67018227" display_stop="67114737" />
      </Location>
      <XRefList>
        <XRef Type="Allelic variant" ID="608160.0016" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="SOX9, 96-KB TRIPLICATION, UPSTREAM REGULATORY REGION AND 46,XX sex reversal 2" Accession="RCV000173015" Version="3">
        <ClassifiedConditionList TraitSetID="7935">
          <ClassifiedCondition DB="MedGen" ID="C2749215">46,XX sex reversal 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-10-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2016-08-22" MostRecentSubmission="2016-08-22">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21653197</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7935" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="8" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SRY-negative 46,XX testicular disorder of sex development</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">46,XX sex reversal 2</ElementValue>
                <XRef ID="MONDO:0010218" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CHROMOSOME 17q24 DUPLICATION SYNDROME</ElementValue>
                <XRef Type="MIM" ID="278850" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">SRXX2</ElementValue>
                <XRef Type="MIM" ID="278850" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15249" />
                <XRef ID="15249" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Nonsyndromic 46,XX testicular disorders/differences of sex development (DSD) are characterized by: the presence of a 46,XX karyotype; external genitalia ranging from typical male to ambiguous; two testicles; azoospermia; absence of m√ºllerian structures; and absence of other syndromic features, such as congenital anomalies outside of the genitourinary system, learning disorders / cognitive impairment, or behavioral issues. Approximately 85% of individuals with nonsyndromic 46,XX testicular DSD present after puberty with normal pubic hair and normal penile size but small testes, gynecomastia, and sterility resulting from azoospermia. Approximately 15% of individuals with nonsyndromic 46,XX testicular DSD present at birth with ambiguous genitalia. Gender role and gender identity are reported as male. If untreated, males with 46,XX testicular DSD experience the consequences of testosterone deficiency.</Attribute>
                <XRef ID="NBK1416" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301589</ID>
                <ID Source="BookShelf">NBK1416</ID>
              </Citation>
              <Citation Type="general" Abbrev="ICCI, 2006">
                <ID Source="PubMed">16882788</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESPU, 2009">
                <ID Source="PubMed">19272837</ID>
              </Citation>
              <XRef ID="393" DB="Orphanet" />
              <XRef ID="C2749215" DB="MedGen" />
              <XRef ID="MONDO:0010218" DB="MONDO" />
              <XRef Type="MIM" ID="278850" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="412350" SubmissionDate="2016-08-03" DateLastUpdated="2016-08-22" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="608160.0016_46,XX SEX REVERSAL 2" title="SOX9, 96-KB TRIPLICATION, UPSTREAM REGULATORY REGION_46,XX SEX REVERSAL 2" />
        <ClinVarAccession Accession="SCV000224034" DateUpdated="2016-08-22" DateCreated="2015-06-28" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 46,XX SRY-negative Italian brothers (SRXX2; 278850), who were phenotypically normal males but had hypotrophic testes and azoospermia, Vetro et al. (2011) identified heterozygosity for a 96-kb triplication located 500 kb upstream of the SOX9 gene on chromosome 17. Array CGH and quantitative PCR analysis defined the proximal breakpoint of the triplication from 67,018,227 bp (normal) to 67,018,939 bp (triplicated), and the distal breakpoint from 67,114,737 bp (triplicated) to 67,119,234 bp (normal; NCBI36). The triplication was not present in their 2 fertile sisters and mother. The 2 brothers shared the same paternal haplotype for the SOX9 region, supporting the possibility that their deceased unaffected father was the carrier of the triplication.</Attribute>
              <Citation>
                <ID Source="PubMed">21653197</ID>
              </Citation>
              <XRef DB="OMIM" ID="278850" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX9" />
          </GeneList>
          <Name>SOX9, 96-KB TRIPLICATION, UPSTREAM REGULATORY REGION</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">96-KB TRIPLICATION, UPSTREAM REGULATORY REGION</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608160.0016" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">46,XX SEX REVERSAL 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="412350" TraitType="Disease" MappingType="Name" MappingValue="46,XX SEX REVERSAL 2" MappingRef="Preferred">
        <MedGen CUI="C2749215" Name="46,XX sex reversal 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

